Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (341-350 of 587) with videos related to

Pageof 59
Sort By:
Plos One|January 5, 2016
Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B StudyXianghai Zhou, Linong Ji, Xingwu Ran, et al.
Chinese Medical Journal|October 20, 2021
Cardiovascular risk profile and clinical characteristics of diabetic patients: a cross-sectional study in ChinaFang Lyu, Xiaoling Cai, Chu Lin, et al.
Journal of Diabetes Investigation|August 19, 2020
Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exerciseLinong Ji, Jianhua Ma, Weiping Lu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 19, 2020
Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in ChinaXia Li, Shuting Yang, Chuqing Cao, et al.
Eclinicalmedicine|June 13, 2020
Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinical trial (the FREE study)Linong Ji, Leili Gao, Liming Chen, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double-blind, placebo-controlled studyLinong Ji, Ling Li, Jianhua Ma, et al.
Diabetes, Obesity & Metabolism|July 9, 2025
Glucagon-like peptide-1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesityJingxuan Wang, Chu Lin, Xiaoling Cai, et al.
Diabetes Research and Clinical Practice|September 16, 2025
Regional, age-specific and sex-specific trends in the prevalence of overweight or obesity in type 1 diabetes from 1980 to 2020: a meta-analysis of 78 observational studies with 650,265 participantsYuchen Guo, Chu Lin, Xiaoling Cai, et al.
Journal of Diabetes and Its Complications|September 27, 2014
Prevalence of microvascular diseases among tertiary care Chinese with early versus late onset of type 2 diabetesLing Li, Linong Ji, Xiaohui Guo, et al.
Diabetes, Obesity & Metabolism|December 3, 2020
Flash glucose monitoring data analysed by detrended fluctuation function on beta-cell function and diabetes classificationWei Liu, Jing Chen, Luxi He, et al.
Pageof 59

Showing results (341-350 of 587) with videos related to

Sort By:
Pageof 59
Plos One|January 5, 2016
Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B StudyXianghai Zhou, Linong Ji, Xingwu Ran, et al.
Chinese Medical Journal|October 20, 2021
Cardiovascular risk profile and clinical characteristics of diabetic patients: a cross-sectional study in ChinaFang Lyu, Xiaoling Cai, Chu Lin, et al.
Journal of Diabetes Investigation|August 19, 2020
Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exerciseLinong Ji, Jianhua Ma, Weiping Lu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 19, 2020
Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in ChinaXia Li, Shuting Yang, Chuqing Cao, et al.
Eclinicalmedicine|June 13, 2020
Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinical trial (the FREE study)Linong Ji, Leili Gao, Liming Chen, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double-blind, placebo-controlled studyLinong Ji, Ling Li, Jianhua Ma, et al.
Diabetes, Obesity & Metabolism|July 9, 2025
Glucagon-like peptide-1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesityJingxuan Wang, Chu Lin, Xiaoling Cai, et al.
Diabetes Research and Clinical Practice|September 16, 2025
Regional, age-specific and sex-specific trends in the prevalence of overweight or obesity in type 1 diabetes from 1980 to 2020: a meta-analysis of 78 observational studies with 650,265 participantsYuchen Guo, Chu Lin, Xiaoling Cai, et al.
Journal of Diabetes and Its Complications|September 27, 2014
Prevalence of microvascular diseases among tertiary care Chinese with early versus late onset of type 2 diabetesLing Li, Linong Ji, Xiaohui Guo, et al.
Diabetes, Obesity & Metabolism|December 3, 2020
Flash glucose monitoring data analysed by detrended fluctuation function on beta-cell function and diabetes classificationWei Liu, Jing Chen, Luxi He, et al.
Pageof 59